Published in Biochem Med (Zagreb) on January 01, 2013
Genetic and epigenetic regulation of gene expression in fetal and adult human livers. BMC Genomics (2014) 1.09
Systemic Transcriptional Alterations of Innate and Adaptive Immune Signaling Pathways in Atherosclerosis, Ischemia Stroke, and Myocardial Infarction. J Bioanal Biomed (2015) 0.77
Effects of Cigarette Smoke Condensate on Oxidative Stress, Apoptotic Cell Death, and HIV Replication in Human Monocytic Cells. PLoS One (2016) 0.77
The association of GSTT1 deletion polymorphism with lung cancer risk among Chinese population: evidence based on a cumulative meta-analysis. Onco Targets Ther (2015) 0.76
Glutathione transferases. Annu Rev Pharmacol Toxicol (2005) 9.67
Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A (1988) 3.75
Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta (2003) 2.16
Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet (2006) 2.15
A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res (1996) 1.74
Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol B (2005) 1.72
Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab (2002) 1.55
Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev (1995) 1.51
Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies--a review. Int J Hyg Environ Health (2008) 1.50
Environmental contaminant-mixture effects on CNS development, plasticity, and behavior. Toxicol Appl Pharmacol (2004) 1.36
Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res (2000) 1.31
CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis (2003) 1.28
Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab (2006) 1.25
The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther (2002) 1.23
Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol (2007) 1.23
Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci (2001) 1.21
Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol (2012) 1.17
Prenatal exposure to polycyclic aromatic hydrocarbons, benzo[a]pyrene-DNA adducts, and genomic DNA methylation in cord blood. Environ Health Perspect (2012) 1.17
Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis (2003) 1.06
GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol (2004) 1.06
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty. J Lipid Res (2012) 1.04
Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J (2005) 1.01
The aryl hydrocarbon receptor system. Drug Metabol Drug Interact (2012) 1.01
PAH-DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms. Mutat Res (2007) 0.99
CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res (2011) 0.99
PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res (1991) 0.96
The environmental carcinogen benzo[a]pyrene induces expression of monocyte-chemoattractant protein-1 in vascular tissue: a possible role in atherogenesis. Mutat Res (2007) 0.95
CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer (2008) 0.94
Endotoxin and polycyclic aromatic hydrocarbons in ambient fine particulate matter from Fresno, California initiate human monocyte inflammatory responses mediated by reactive oxygen species. Toxicol In Vitro (2010) 0.94
Association between glutathione S-transferase polymorphisms and triglycerides and HDL-cholesterol. Atherosclerosis (2009) 0.93
A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis (2005) 0.91
Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses. Circ Cardiovasc Genet (2011) 0.90
DNA repair gene polymorphism is associated with the genetic basis of atherosclerotic coronary artery disease. Cardiovasc Pathol (2010) 0.88
Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur J Pharm Sci (2006) 0.88
GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Mutat Res (2007) 0.87
Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci (2012) 0.87
Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis (2002) 0.86
Induction of intracellular calcium concentration by environmental benzo(a)pyrene involves a β2-adrenergic receptor/adenylyl cyclase/Epac-1/inositol 1,4,5-trisphosphate pathway in endothelial cells. J Biol Chem (2011) 0.86
Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease. DNA Cell Biol (2011) 0.86
Obesity: genome and environment interactions. Arh Hig Rada Toksikol (2012) 0.86
Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Mutat Res (2012) 0.86
Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World J Surg (2005) 0.85
Exposure to polycyclic aromatic hydrocarbons: bulky DNA adducts and cellular responses. EXS (2012) 0.84
Induction of cytochrome P-450 in the Norway rat, Rattus norvegicus, following exposure to potential environmental contaminants. J Toxicol Environ Health (1995) 0.84
Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus. Pharmacogenomics (2009) 0.84
Is there a genetic basis for resistance to atherosclerosis? Atherosclerosis (2002) 0.83
Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol (2012) 0.83
Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases. BMC Evol Biol (2010) 0.83
Up-regulation of the glutathione S-transferase system in human liver by polycyclic aromatic hydrocarbons; comparison with rat liver and lung. Mutagenesis (2008) 0.82
Hydrocarbons and kidney damage: potential use of neutrophil gelatinase-associated lipocalin and sister chromatide exchange. Am J Nephrol (2012) 0.82
Retracted NAD(P)H:quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBPα leading to its stabilization and protection against radiation-induced myeloproliferative disease. J Biol Chem (2012) 0.82
Measuring nonpolar organic contaminant partitioning in three Norwegian sediments using polyethylene passive samplers. Sci Total Environ (2012) 0.81
The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro. Diabetologia (2009) 0.80
CYP1A1 and GSTM1/T1 genetic variation in predicting risk for cerebral infarction. J Mol Neurosci (2007) 0.79
Fluoranthene enhances p53 expression and decreases mutagenesis induced by benzo[a]pyrene. Toxicol Lett (2011) 0.79
Metabolically competent human skin models: activation and genotoxicity of benzo[a]pyrene. Toxicol Sci (2012) 0.78
A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun (2005) 0.78
Survival of atherosclerotic patients as related to oxidative stress and gene polymorphisms. Mutat Res (2007) 0.78
CYP1A1-mediated mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun (2005) 0.77
[Polycyclic aromatic hydrocarbons in air]. Arh Hig Rada Toksikol (2011) 0.76
Deciphering the traits associated with PAH degradation by a novel Serratia marcesencs L-11 strain. J Environ Sci Health A Tox Hazard Subst Environ Eng (2012) 0.76
Phase II enzymes and bioactivation. Can J Physiol Pharmacol (1995) 0.76
Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease. Clin Chem Lab Med (2003) 0.76
[Influence of gene polymorphisms in adhesion molecules and inflammation mediators as risk factors for coronary heart disease and myocardial infarction--an overview]. Acta Med Croatica (2008) 0.75
Genotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholars. Coll Antropol (2008) 0.75